H-Index
17
Scimago Lab
powered by Scopus
eISSN: 1941-5923
call: +1.631.629.4328
Mon-Fri 10 am - 2 pm EST

Logo

Medical Science Monitor Basic Research
MSMbanner

Annals
ISI-Home

Malignant pleural effusion in breast cancer 12 years after mastectomy that was successfully treated with endocrine therapy

Unusual clinical course, Unusual or unexpected effect of treatment, Unexpected drug reaction , Educational Purpose (only if useful for a systematic review or synthesis)

Tsuyoshi Shinohara, Hiroyuki Yamada, Yoshiro Fujimori, Kiyofumi Yamagishi

Japan Nakano, Japan

Am J Case Rep 2013; 14:184-187

DOI: 10.12659/AJCR.889249

Available online:

Published: 2013-06-03


#889249

Background:   The most common site of postoperative breast cancer recurrence is bone, followed by local relapse, lung, and liver. The majority of relapses occur within the first 3 years after surgery. Pleural recurrences more than 10 years after surgery are rare.
Case Report:  A 94-year-old woman who had undergone modified radical mastectomy for right breast cancer (invasive ductal carcinoma, pT2, pN1, ER+, PgR+) 12 years earlier presented to our hospital with carcinomatous pleuritis and a chief complaint of dyspnea. Endocrine therapy with oral letrozole was started and the pleural effusion had disappeared 3 months later.
Conclusions: Oral endocrine therapy may be effective for the treatment of late recurrence of hormon receptor-positive breast cancer in elderly women.

Keywords: endocrine therapy, breast cancer, late recurrence, Malignant pleural effusion



Back